Impact of anti-CD20 monoclonal antibodies on serologic response to
Por um escritor misterioso
Descrição
JCI Insight - Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
Mechanisms of killing by anti-CD20 monoclonal antibodies - ScienceDirect
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Role of Pharmacist Intervention in the Safe Administration of Anti-CD20 Monoclonal Antibodies
The future of anti-CD 20 monoclonal antibodies : are we making progress ?
Frontiers Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Vaccination and immunotherapies in neuroimmunological diseases
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico: Cell
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis - eBioMedicine
Humoral and cellular responses after a third dose of BNT162b2 vaccine in patients treated for lymphoid malignancies
Overview of therapeutic monoclonal antibodies - UpToDate
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
de
por adulto (o preço varia de acordo com o tamanho do grupo)
